Bio Medica Laboratories Ltd Share Price

Pharmaceuticals

NSE: BMLL Small Cap ISIN: INE1BKA01015

As on 13 June 2026 at 01:11 IST

₹124.50

+ 5.30

(4.45%)

Sell Buy

Over 1 Month

2.94%

Over 6 Months

None%

Over 1 Year

None%

Over 3 Years

None%

Bio Medica Laboratories Ltd Summary

Close ₹119.20

Open ₹120

High ₹123.90

Low ₹118.60

Volume 4,53,000

Net Turnover (in Cr) ₹5.39

52Wk High -

52Wk Low -

52Wk High / Low

Bio Medica Laboratories Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹149.89

EPS (TTM) -

Book Value (BV) 49.24

Div. Yield -

P/E (TTM) -

Price/Book Value 2.42

Delivery % 71.52 %

Face Value 10

Key Ratios

PE Ratio -

PB Ratio -

EV to Sales -

PEG Ratio -

ROA 32.24

ROE 99.54

Debt-Equity 1.30

Net Profit Margin 25.63

Operating Profit Margin 40.58

Bio Medica Laboratories Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

No data available

Balance Sheet

No data available

Cash Flow

No data available

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Total Revenue	38.33	15.34	16.25
Total Expenses	25.18	11.69	15.80
Profit Before Tax	13.14	3.65	0.45
Profit After Tax	9.79	2.50	0.33
Operating Profit After Depreciation	14.34	4.62	1.22

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Fixed Assets	7.68	8.73	8.31
Total Non Current Assets	8.03	8.98	8.47
Total Current Assets	31.09	10.55	9.10
Total Assets	39.12	19.53	17.57
Total Shareholder's Fund	14.73	4.94	2.44

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023
Net Cash From Operating Activities	-3.67	1.62	2.29
Net Cash Used In Investing Activities	0.34	-1.54	-1.69
Net Cash Used In Financing Activities	3.33	-0.08	-2.13

No data available

Bio Medica Laboratories Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 117.23

S2 115.27

S3 111.93

Pivot 120.57

R1 122.53

R2 125.87

R3 127.83

Moving Average

20 SMA -

50 SMA -

100 SMA -

200 SMA -

Bio Medica Laboratories Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Bio Medica Laboratories Ltd Top Mutal Funds Invested

No data available

Bio Medica Laboratories Ltd News

NSE SME Bio Medica Laboratories begins market journey on a weak note

Bio Medica Laboratories traded at Rs 105.65 on the NSE, a discount of 23.99% compared with the issue price of Rs 139.

29 May 2026, 11:50 am

Bio Medica Laboratories Ltd Stock Analysis

Annual revenue for Bio Medica Laboratories Ltd increased by 149.77% to ₹38.33 crore in FY 2025 from ₹15.34 crore in FY 2024.
Annual Net Profit for Bio Medica Laboratories Ltd increased by 292.00% to ₹9.79 crore in FY 2025 from ₹2.50 crore in FY 2024.
Promoter Shareholding in Bio Medica Laboratories Ltd increased by 43.05% in the most recent quarter, from 67.70% in May 2026 to 96.84% in May 2026.
Bio Medica Laboratories Ltd delivered a 1-year return of 0% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Bio Medica Laboratories Ltd share price moved up by 4.45% from its previous close of INR ₹119.20. The latest Bio Medica Laboratories Ltd share price is INR ₹124.50.
Bio Medica Laboratories Ltd share price today has been at a low of 121 and a high of 127.90. Over the past 52 weeks, the Bio Medica Laboratories Ltd share price has seen a low of 101.50 and a high of 133.95.